Gut Lactic Acid and Akkermansia Team Up to Ease Anxiety via Serotonin
A gut microbiome study links lactic acid and Akkermansia muciniphila to reduced anxiety by boosting serotonin production from tryptophan.
Summary
Researchers studying 110 elite shooting athletes found that higher fecal lactate levels correlated with lower anxiety scores, and that Akkermansia abundance was negatively associated with anxiety. In mouse models, co-supplementation with sodium lactate and live Akkermansia muciniphila shifted tryptophan metabolism away from the kynurenine pathway and toward serotonin (5-HT) production, increasing the enzyme TPH1 and reducing IDO1. Lactate also boosted A. muciniphila's propionate output, which independently alleviated anxiety-like behaviors. Together, these gut-derived signals—lactic acid and A. muciniphila—appear to collaboratively correct tryptophan metabolism imbalances, raising serotonin activity and reducing anxiety phenotypes in both human observational and controlled animal models.
Detailed Summary
Anxiety disorders are the world's most prevalent mental health condition, and disrupted serotonin (5-HT) signaling is a well-established contributor. Because ~95% of the body's serotonin is produced in the gut from tryptophan, the gut microbiome is a logical but underexplored lever for anxiety regulation. This study asked whether specific microbial metabolites—particularly lactic acid—could modulate tryptophan-to-serotonin conversion and anxiety outcomes.
The researchers recruited 110 elite Chinese shooting athletes in a closed training environment, a cohort uniquely suited to minimize confounding lifestyle variables. Participants completed validated anxiety questionnaires (GAD-7, STAI-T, CSAI-2) and provided fecal samples. Higher fecal lactate correlated significantly with lower anxiety scores, and Akkermansia abundance showed a significant negative correlation with anxiety levels. These observational findings motivated mechanistic animal experiments.
In mouse models using chronic unpredictable mild stress (CUMS) to induce anxiety, daily intraperitoneal sodium lactate injections reduced anxiety-like behavior in open-field and elevated plus maze tests. Crucially, antibiotic-depleted mice colonized with live A. muciniphila plus lactate showed the greatest anxiety reduction, outperforming either intervention alone or heat-killed bacteria controls. Mechanistically, the lactate + A. muciniphila combination increased intestinal TPH1 (tryptophan hydroxylase 1, the rate-limiting enzyme for 5-HT synthesis) and decreased IDO1 (indoleamine 2,3-dioxygenase 1, which diverts tryptophan toward kynurenine), thereby redirecting tryptophan flux toward serotonin. Colonic and plasma 5-HT levels rose, while kynurenine levels fell.
Lactate also enhanced A. muciniphila's production of propionate, a short-chain fatty acid with known anxiolytic properties. Oral calcium propionate supplementation in antibiotic-treated mice recapitulated the anxiety-reducing effects, confirming propionate as a downstream effector. Germ-free mouse experiments further validated that A. muciniphila colonization alone was sufficient to alter tryptophan metabolism, and that lactate amplified this effect.
These findings map a previously uncharacterized gut-brain axis pathway: exercise or dietary-derived enteric lactate nourishes and potentiates A. muciniphila, which in turn elevates propionate and rebalances tryptophan metabolism toward serotonin synthesis, collectively dampening anxiety. The study opens potential for microbiota-targeted interventions—such as lactate-boosting diets, probiotic A. muciniphila, or propionate supplementation—as adjunct strategies for anxiety management.
Key Findings
- Higher fecal lactate levels significantly correlated with lower anxiety scores in 110 elite athletes.
- Akkermansia muciniphila abundance was negatively correlated with anxiety levels in the athlete cohort.
- Lactate + live A. muciniphila co-treatment increased TPH1 and decreased IDO1, shifting tryptophan toward serotonin over kynurenine.
- Lactate enhanced A. muciniphila propionate production; oral propionate alone reduced anxiety-like behavior in mice.
- Heat-killed A. muciniphila failed to replicate the anxiolytic effects, confirming the need for viable bacteria.
Methodology
Observational study of 110 athletes using validated anxiety scales (GAD-7, STAI-T, CSAI-2) and fecal metabolomics; mechanistic validation in C57BL/6 mice using CUMS anxiety model, antibiotic depletion, bacterial colonization, and germ-free experiments. Tryptophan pathway enzymes (TPH1, IDO1), 5-HT levels, and short-chain fatty acids were quantified in gut tissue and plasma.
Study Limitations
The human component is observational and limited to elite athletes, limiting generalizability to broader populations. Mouse models use pharmacological sodium lactate injections rather than physiological gut lactate production, which may not fully mirror human conditions. The precise molecular mechanism by which lactate signals to A. muciniphila to upregulate propionate synthesis remains to be fully characterized.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
